Trial Profile
A retrospective study of Tenofovir in HIV-infected patients to evaluate the associated risk of chronic kidney disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 05 Feb 2016 New trial record
- 11 Jan 2016 Results published in the AIDS